This month’s journal-based CME article is titled "Feasibility of boosted radioembolization for hepatocellular carcinoma larger than 5 cm".
Initial reports suggest that boosted radioembolization with adjusted dose based on MAA SPECT/CT may improve clinical outcomes in patients with tumors larger than 5 cm. There is growing consensus that super-selective administration of y-90, similar to the technique used for chemoembolization, may enhance the therapeutic effect and reduce potential complications for large HCCs. Thus, the aim of this retrospective study was to address the feasibility of yttrium-90 glass microspheres of boosted dose in large HCC.
This program is designed to meet the educational needs of interventional radiologists, medical oncologissts, radiation oncologists, hepatobiliary and transplant surgeons, nurses, techs, and trainees at all levels with special interest in stroke.
To receive CME credit for this journal-based CME activity, participants must read the journal article and score 75% or better on the post test. Participants will have three opportunities to score 75% or better.
After participating in this journal-based CME activity, learners should be able to
Describe expected response rates for successfully treated tumors using the mRECIST criteria
List Progression free survival at one year for patients with large HCCs treated with Y-90
Cite the incidence of complications, specifically biliary dilatation and/or stricture following Y-90 with a booster dose.
JVIR CME Editor
Nishita Kothary, MD
Stanford University Medical Center, Stanford CA
Hyo-Cheol Kim, MD
Yoon Jun Lee
Jim Wook Chung
Department of Radiology, Seoul National University Hospital; Seoul, Korea
Conflicts of Interest:
None of the authors have identified a conflict of interest.
None of the authors have financial disclosures. This report was presented at SIR 2018 Annual Scientific Meeting as an e-poster.
Scientific Advisor, Siemens Healthcare
This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME).
The Society of Interventional Radiology (SIR) is accredited by the ACCME to provide continuing medical education for physicians. SIR designates this education activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program is approved for 1 self-assessment CME credit (SA-CME) by the Society of Interventional Radiology (SIR) - approved December 1, 2018. SIR is awarded Deemed Status by the American Board of Radiology (ABR). The SA-CME credit offered for this enduring activity meets the ABR’s criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification (MOC) Program.